Login / Signup

Bruxism: Best Evidence Consensus Statement.

Gary R GoldsteinLouis DeSantisCharles J Goodacre
Published in: Journal of prosthodontics : official journal of the American College of Prosthodontists (2021)
Due to variations in demographics and the dependence on anamnestic data, the true prevalence of bruxism in any specific population is unknown. There is moderate evidence that psychosocial factors such as stress, mood, distress, nervousness, and feeling blue are associated with sleep bruxism (SB) as well as caffeine, alcohol, and smoking. There is no consensus on what symptoms of SB or awake bruxism (AB) should be treated. There is some evidence that occlusal devices and bio feedback therapies can be utilized in SB treatment. There is conflicting evidence in the use of Botulinum toxin A and no compelling evidence for the use of drug therapy to treat SB. There is not an established cure for bruxism. The clinician is best served in using caution in the dental rehabilitation of patients with severe occlusal wear.
Keyphrases
  • botulinum toxin
  • sleep quality
  • bipolar disorder
  • stem cells
  • machine learning
  • emergency department
  • physical activity
  • bone marrow
  • high intensity
  • deep brain stimulation
  • newly diagnosed
  • cell therapy
  • combination therapy